We show that human CD34(+) cells expressing PDGFR fusion oncogenes proliferate autonomously and differentiate towards the eosinophil lineage in a process that requires nuclear factor-κB. These results suggest new treatment possibilities for imatinib-resistant myeloid neoplasms associated with PDGFR mutations.
No takes yet. Share an insight, caveat, or question.
Montano‐Almendras et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: